Morphologically similar epithelial and stromal cells in primary bilateral breast tumor display different genetic profiles: Implications for treatment

Applied Immunohistochemistry and Molecular Morphology

Volumn 12, Issue 4, 2004, Pages 305-314

  Man, Yan Gao ^a   Magrane, Gregg G ^b   Lininger, Ruth A ^a,c   Shen, Ting ^a,d   Kuhls, Elizabeth ^a   Bratthauer, Gary L ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Bilateral primary breast tumor; Comparative genomic hybridization; Loss of heterozygosity; Microsatellite instability; Stromal epithelial interaction

Indexed keywords

DNA MARKER;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST METASTASIS; CELL INTERACTION; CELL STRUCTURE; CHROMOSOMAL LOCALIZATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE COURSE; DNA EXTRACTION; EPITHELIUM CELL; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC MARKER; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG SMALL CELL CANCER; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; STROMA CELL;

EID: 10044277950     PISSN: 15412016     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129039-200412000-00004     Document Type: Article

References (40)

1. Fisher ER, Fisher B, Sass R, et al. and collaborating NSABP investigators. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4.). XI. Bilateral breast cancer. Cancer. 1984;54:3002-3011.
2. Kollias J, Ellis IO, Elston CW, et al. Prognostic significance of synchronous and metachronous bilateral breast cancer. World J Surg. 2001;25:1117-1124.
3. Donovan AJ. Bilateral breast cancer. Surg Clin North Am. 1990;70:1141-1149.
4. Hoffman E. The contralateral breast biopsy in ipsilateral carcinoma. South Med J. 1990;83:1009-1015.
5. Ringberg A, Palmer B, Linell F, et al. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ. Eur J Surg Oncol. 1991;17:20-29.
6. Nielsen M, Christensen L, Andersen J. Contralateral cancerous breast lesions in women with clinical invasive breast carcinoma. Cancer. 1986;57:897-903.
7. Lawson R. Mammary cancer: the other breast. Can Med Assoc J. 1955; 73:676-677.
8. Masood S. Occult breast lesions and aspiration biopsy: a new challenge. Diagn Cytopathol. 1993;9:613-614.
9. Barton FE Jr. Breast cancer, subcutaneous mastectomy, breast reconstruction. Selected Readings Plastic Surg. 1986;3:1-23.
10. Ronnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev. 1996;76:69-125.
11. Fracchia AA, Robinson D, Legaspi A, et al. Survival in bilateral breast cancer. Cancer. 1985;55:1414-1421.
12. Staren ED, Robinson DA, Wir TR, et al. Synchronous, bilateral mastectomy. J Surg Oncol. 1995;59:75-79.
13. Healey EA, Cook EF, Orav EJ, et al. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol. 1993;11:1545-1552.
14. Sterns EE, Fletcher WA. Bilateral cancer of the breast: a review of clinical, histologic and immunohistologic characteristics. Surgery. 1991;110:617-622.
15. Hungness ES, Safa M, Shaughness EA, et al. Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. Surgery. 2000;128:702-707.
16. Dawson LA, Chow E, Goss PE. Evolving perspectives in contralateral breast cancer. Eur J Cancer. 1998;34:2000-2009.
17. Moinfar F, Man YG, Arnould A, et al. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res. 2000;60:2562-2566.
18. Moinfar F, Man YG, Bratthauer GL, et al. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type (clinging ductal carcinoma in situ): a simulator of normal mammary epithelium. Cancer. 2000;88:2072-2081.
19. Man YG, Mannion C, Kuhls E, et al. Allelic losses at 3p and 11p are detected in both epithelial and stromal components of cervical small-cell neuroendocrine carcinoma. Appl Immunohistochem Mol Morphol. 2001;9:340-345.
20. Man YG, Moinfar F, Bratthauer GL, et al. An improve method for DNA extraction from paraffin sections. Pathol Res Pract. 2001;197:635-642.
21. Man YG, Moinfar F, Bratthauer GL, et al. Five useful hits for making more valid gel images of loss of heterozygosity and clonality analysis with a 377 DNA sequencer. Diagn Mol Pathol. 2000;9:84-90.
22. Man YG, Kuhls EA, Bratthauer GL, et al. Multiple use of slab gels in sequencing apparatus for separation of PCR products. Electrophoresis. 2001;22:1915-1919.
23. Kallionniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992;258:818-821.
24. Ried T, Just KE, Holtgreve-Grez H, et al. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res. 1995;55:5415-5423.
25. Kollias J, Man S, Marafie M, et al. Loss of heterozygosity in bilateral breast cancer. Breast Cancer Res Treat. 2000;64:241-251.
26. Simian M, Hirai Y, Navre M, et al. The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development. 2001;128:3117-3131.
27. Bissell MJ, Radisky DC, Rizki A, et al. The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation. 2002;70:537-546.
28. Zhaung Z, Lininger RA, Man YG, et al. Identical clonality of both components of mammary carcinosarcoma with differential loss of heterozygosity. Mod Pathol. 1997;10:354-362.
29. Sell S, Pierce GB. Maturation arrest of stem cells is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest. 1994;70:6-22.
30. Kordon EC, Smith GH. An entire functional mammary gland may comprise the progeny from a single cell. Development. 1998;125:1921-1930.
31. Drummond R. The malignant stem cells. Med Hypotheses. 1994;43:157-159.
32. Wingo PA, Ries LA, Rosenberg HM, et al. Cancer incidence and mortality, 1973-1995: a report card for the U.S. Cancer. 1998;82:1197-1207.
33. Schedin P, Strange R, Mitrenga T. Fibronectin fragments induce MM activity in mouse mammary epithelial cells: evidence for a role in mammary tissue remodeling. J Cell Sci. 1995;113:795-806.
34. Werb Z, Ashkenas J, MacAuley A, et al. Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis. Braz J Med Biol Res. 1996;29:1087-1097.
35. McCawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today. 2000;6:149-156.
36. Hansen RK, Bissell MJ. Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones. Endocr Relat Cancer. 2000;7:95-113.
37. Nelson AR, Fingleton B, Rothenberg ML, et al. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol. 2000;18:1135-1149.
38. Lininger RA, Fujii H, Man YG, et al. Comparison of loss heterozygosity in primary and recurrent ductal carcinoma in situ of the breast. Mod Pathol. 1998;11:1151-1159.
39. Cooper M, Pinkus H. Intrauterine transplantation of rat basal cell carcinoma as a model for reconversion of malignant to benign growth. Cancer Res. 1977;37:2544-2552.
40. Fibach E, Landau T, Sachs L. Normal differentiation of myeloid leukaemic cells induced by a differentiation-inducing protein. Nat New Biol. 1972;237:276-278.